Brighter Company

Data-driven solutions for smarter treatment of chronic conditions. Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Tackling diabetes first. Brighter is currently focused on treating the global diabetes epidemic by launching Actiste® Diabetes Management as a Service. https://actiste.com/ The Actiste device is based on patented technology for the remote monitoring and collection of data on specified bio-markers and volumes of medication injected. We believe this data-centric approach is key to providing smarter care for both diabetes and other chronic conditions too. Why Actiste? A video explaining the diabetes care service Actiste: https://youtu.be/qLWfTUbl3eM Brighter’s business model includes out-licensed rights to its platform. A business-critical part of Brighter’s operations involves continuous IP portfolio development—via its own applications and in-licensing (for example, the micro-needle technology in-licensing that Brighter acquired for blood sugar monitoring).

Founded Date: 2007-01-01
Last Funding Type: Series B
Headquarters: Kista, Stockholms Lan, Sweden
Investors Number: 11
Technology: Others
Employee Number: 11-50
Industry: Health Care, Information Technology
Estimated Revenue: $1M to $10M
Funding Status: IPO
Investor Type: For Profit
Total Funding: $24.5M